A Study to Evaluate the Long-term Safety of Arbaclofen Extended-Release Tablets for Patients With Spasticity Due to MS

NCT03319732 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

323

Enrollment

INDUSTRY

Sponsor class

Conditions

Multiple Sclerosis
Spasticity, Muscle

Interventions

DRUG: Arbaclofen

Sponsor

RVL Pharmaceuticals, Inc.

Collaborators

[object Object]